Routine Evaluation of a 32-Week Preterm Infant at 6 Weeks Chronological Age
For a 32-week preterm infant now 6 weeks old (approximately 38 weeks corrected age), prioritize RSV prophylaxis assessment, feeding/growth evaluation, and neurodevelopmental screening, while cranial ultrasound is not routinely indicated at this gestational age.
RSV Prophylaxis Assessment
This infant does NOT automatically qualify for palivizumab prophylaxis based on gestational age alone. According to AAP guidelines, infants born at exactly 32 weeks 0 days gestation fall into a specific category that requires risk factor assessment 1.
Decision Algorithm for RSV Prophylaxis:
If born at 32 weeks 0 days exactly: Qualifies ONLY if at least one of these risk factors is present:
- Attends child care, OR
- Has ≥1 sibling or child <5 years living in household 1
If these criteria are met: Administer palivizumab until 90 days of age OR maximum 3 doses (whichever comes first) 1
If born <32 weeks 0 days: Qualifies regardless of risk factors for up to 5 monthly doses throughout RSV season 1
Critical timing consideration: At 6 weeks chronological age, if RSV season is active and criteria are met, initiate prophylaxis immediately as the infant is still within the 90-day window 1.
Growth and Feeding Evaluation
Assess three physiologic competencies essential for preterm infant stability 2:
Oral feeding sufficiency:
- Verify adequate weight gain trajectory
- Confirm infant can maintain growth on oral feeds alone
- Most preterm infants achieve this by 36-37 weeks postmenstrual age (this infant is now ~38 weeks) 2
Thermoregulation:
- Ensure infant maintains normal body temperature in home environment
- Should be stable without incubator support 2
Respiratory control maturity:
Neurodevelopmental Screening
Perform standardized neurodevelopmental assessment corrected for gestational age 3:
- Motor function: Assess for cerebral palsy signs (hypertonia, hypotonia, weakness with increased deep tendon reflexes)
- Vision: Check for strabismus, visual impairment
- Hearing: Formal brainstem auditory evoked potential response should be completed 3
- Head circumference: Measure for microcephaly or macrocephaly
- Neurologic exam: Evaluate for hemiparesis
Use corrected age (subtract weeks of prematurity from chronological age) for developmental milestone assessment in the first 2 years 3.
Cranial Ultrasound
Routine cranial ultrasound is NOT indicated for this infant. The evidence strongly supports limiting screening ultrasound to infants <30 weeks gestation 4.
- A study of 486 infants 30-33 weeks gestation found only 0.8% had grade III/IV IVH and 1.4% had PVL 4
- All infants with significant findings had either risk factors or symptoms that would warrant ultrasound regardless 4
- Only perform cranial ultrasound if: Clinical symptoms develop (seizures, apnea, abnormal neurologic exam) or specific risk factors for brain injury are present 4
Ophthalmologic Examination
ROP screening depends on specific birth parameters 3:
- Screen if: Born <32 weeks gestation OR had unstable medical course requiring supplemental oxygen 3
- Do NOT screen if: Born >37 weeks OR born 29-37 weeks with "medically stable" course 3
- First exam should occur at 31-33 weeks postmenstrual age or 4 weeks chronological age 3
- At 6 weeks chronological age (38 weeks corrected), this infant should have already been screened if indicated
SIDS Prevention Counseling
Provide explicit supine sleep positioning education 2:
- Infant must sleep supine (back) for every sleep
- Should have been acclimated to supine positioning from 32 weeks postmenstrual age during hospitalization 2
- Counsel about positional skull deformity risk (cosmetic only) 2
Follow-up Care Coordination
Ensure established care with provider experienced in high-risk infant management 2:
- Schedule follow-up within 1-2 weeks of any recent discharge
- Arrange organized tracking program for growth and development surveillance 2
- Late preterm infants (34-37 weeks) have increased risk of feeding problems and hyperbilirubinemia requiring close monitoring 2
Common Pitfalls to Avoid
- Do not assume all 32-week infants need palivizumab - verify exact gestational age and risk factors 1
- Do not order routine cranial ultrasound - this wastes resources and is not evidence-based for ≥30 weeks gestation 4
- Do not use uncorrected age for developmental assessment - always correct for prematurity in first 2 years 3
- Do not prescribe home apnea monitors - these do not prevent SIDS and are not indicated for resolved apnea of prematurity 2